The aim of this study was to evaluate the cultivation potential of cartilage taken from the debrided edge of a chronic lesion of the articular surface. A total of 14 patients underwent arthroscopy of the knee for a chronic lesion on the femoral condyles or trochlea. In addition to the routine cartilage biopsy, a second biopsy of cartilage was taken from the edge of the lesion. The cells isolated from both sources underwent parallel cultivation as monolayer and three-dimensional ( Our results suggest that the cultivation of chondrocytes solely from the edges of the lesion cannot be recommended for use in autologous chondrocyte implantation.
Autologous chondrocyte implantation (ACI) is indicated principally for medium to large fullthickness lesions of the articular surface of large joints. 1, 2 The classic ACI technique, that of a cell suspension injected under a sutured periosteal cover, has been increasingly replaced by various less invasive scaffold-based technologies. 3 A small full-thickness cartilage biopsy from a healthy area of the articular surface is essential for cell cultivation, regardless of the type of graft. The supratrochlear or intercondylar surfaces are routinely harvested in the knee joint. 4 Even a small biopsy is an additional injury to the articular surface that cannot heal spontaneously. No studies have yet shown an effect of biopsy on knee function. Nonetheless, alternative sources of cells such as detached osteochondral fragments, autologous auricular cartilage, allogenic articular cartilage and mesenchymal stem cells, [5] [6] [7] [8] [9] have been explored and some of them used in small clinical series. A further potential source of autologous cells for chondrocyte cultivation is the edge of the cartilage next to the lesion itself. Each lesion needs to be thoroughly debrided of macroscopically diseased tissue (fibrosis, degenerative or loose cartilage and sclerotic bone) before any further procedure. 4 During this process macroscopically intact cartilage is also removed to create a contained lesion with a rim of healthy cartilage. 10 The purpose of this study was to evaluate the cultivation potential (cell yield, viability, proliferation capacity, morphology and gene expression analysis) of cells from the edge of the lesion and compare their characteristics with those of cells from the standard locations for harvesting. We hypothesised that all the characteristics listed above would be lower in the cartilage biopsies taken from the edge of the lesion.
Materials and Methods
A total of 14 patients with a mean age of 30.3 years (19 to 43) underwent an arthroscopy of the knee for a chronic focal cartilage lesion on the femoral condyles or trochlea. The lesion was the result of osteochondritis dissecans in seven, trauma in four, and localised degenerative disease in three. Ten patients had not been treated previously, three had undergone bone-marrow stimulation more than eight months earlier and one had undergone an osteoarticular transfer system procedure 1.8 years earlier. In addition to the routine supratrochlear (ten patients) or intercondylar (four) cartilage biopsy (20 mg to 156 mg), a secondary biopsy was taken from the edge of the lesion (Fig. 1) . Particular care was taken to harvest two grasp bites (45 mg to 128 mg) of macroscopically intact cartilage from the area that was going to be debrided during the following chondrocyte seeding procedure. The study protocol was approved by the National Medical Ethics Committee (No. 91/05/05); all patients gave their written consent for surplus biopsy material to be used in laboratory research.
Each sample of articular cartilage was diced into small pieces and collected in Dulbecco's Modified Eagle Medium (DMEM)/F-12, to which was added 50 µg/ml of gentamicin and 1 mg/ml of collagenase type II (both Gibco, Paisley, United Kingdom) within 24 hours of procurement. Next, the samples were digested for 18 hours at 37°C. After washing and re-suspending in DMEM/F-12 medium, the number and viability of the cells was assessed using the Trypan blue exclusion method with a haemocytometer. Isolated chondrocytes were cultivated in parallel in monolayer cell cultures and in alginate hydrogels. In order to obtain the primary culture cells (P0), chondrocytes from the digested biopsies were seeded in tissue culture flasks at a density of 3000 cells/cm 2 . Cells were detached using trypsin-EDTA solution (Sigma, St Louis, Missouri) when 80% confluency was achieved. The protocol was repeated to obtain the first-passage cells (P1). In order to compare the expansion characteristics of both cell types, cumulative population doublings were calculated using the formula described by Cristofalo et al, 11 and the population doubling for P0 and P1 were calculated and added to acquire the cumulated doubling level. The re-differentiation process was induced by seeding P1 chondrocytes into alginate hydrogel. The 1% (w/v) alginate solutions (MediAlg MG17; Medipol, Lausanne, Switzerland) were prepared in phosphate-buffered saline (PBS) under sterile conditions. Appropriate volumes of the solution and primary cells (P1) were combined to prepare suspensions with a final cell density of 1 × 10 6 cells/ml. The resulting cell-alginate suspensions were gelled by 125 mM CaC1 2 solution (Merck, Darmstadt, Germany) for 15 minutes into spherical constructs within a mould. Once gelled, the constructs (7 mm in diameter, 2 mm high) were removed from the mould, washed thoroughly with PBS, and cultured for 14 days. The growth medium for all cultures (DMEM/F-12, 15% (v/v) heterologous human serum and 50 µg/ml gentamicin) was changed twice weekly. Cells were cultured in a humidified incubator at 37°C and 5% CO 2 .
In order to quantify the expression of cartilage-specific genes for both sources of biopsy, mRNA levels from the biopsy, monolayer culture cells and alginate constructs were analysed using the real-time polymer chain reaction (PCR) method. Total RNA was isolated using TRI REAGENT (Sigma-Aldrich, St Louis, Missouri) according to the manufacturer's protocol. The purity and amount of RNA were determined spectrophotometrically by measuring OD 260/280 . One microgram of total RNA was reverse transcribed to cDNA using the High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, California) according to the instructions. Until use, cDNA was stored at -20°C. PCR reactions were performed and monitored using the ABI Prism 7900HT Sequence Detection System (Applied Biosystems). TaqMan Universal PCR Master Mix and TaqMan Gene Expression Assays -Assays on Demand for collagen type I (COL1; Hs00164004), collagen type II (COL2; Hs001565568), aggrecan (AGR; Hs00202971), and versican (VER; Hs00171642) were used. Human GAPD (GAPDH) Endogenous Control was chosen as the housekeeping gene. All chemicals were purchased from Applied Biosystems. cDNA samples were analysed in duplicate. Data were analysed with the ABI Prism 7900HT Sequence Detection System version 2.1 software (Applied Biosystems). In real time PCR assay a positive reaction is detected by accumulation of a fluorescent signal. The cycle threshold (Ct) is defined as the number of cycles required for the fluorescent signal to cross the threshold (exceed the background level). Ct levels are inversely proportional to the amount of target nucleic acid in the sample. The Ct value of the house-keeping gene was subtracted from that of the target sequence, in order to calculate ∆Ct. Gene expression was assessed by relative quantification. In order to be sure that the amplication efficiencies for each gene were similar, serial dilutions of cDNA were analysed and standard efficiency curves were obtained. All the amplication efficiencies were in the range of 0.93 to 0.96, therefore gene expressions were calculated using the formula 2 The differentiation indices were also calculated. These are defined as the ratios of mRNA levels of collagen type II to type I (COL2/COL1) and aggrecan to versican (AGR/ VER). 12 A higher value indicates a more hyaline-like gene expression, whereas smaller values indicate a more fibroblast-like phenotype. Statistical analysis. The data are presented as the median and range values because of high inter-individual variability. The characteristics of control and lesion biopsies (cell yield, viability, proliferation capacity, gene expressions and differentiation indices) were compared by the non-parametric Mann-Whitney U test. SPSS version 15.0.0 (SPSS Inc., Chicago, Illinois) for Windows was used for the statistical analysis, with the level of significance set at p ≤ 0.05.
Results
The cartilage from the edge of the lesion gave a significantly (p = 0.047) lower mean cell yield (341 cells/mg (268 to 1229)) than the control biopsies (1346 cells/mg (670 to 1560)), but cell viability exceeded 90% regardless of the source. The proliferation capacity, calculated as the mean cumulative population doublings after proliferation, were comparable between the control (8.9 (8.0 to 9.1)) and lesion biopsies (8.5 (7.0 to 10.3)). Inspection of the monolayer cultures revealed similarly shaped fibroblasts in both cell types (Fig. 2) .
The relative gene expression values of chondrocytes obtained from the normal harvesting procedure and from the edge of the lesion are presented in Table I . In summary, the expression of cartilage-specific genes in biopsy samples of debrided tissue revealed lower COL2 (p = 0.867) and AGR (p = 0.022) and higher COL1 expressions (p = 0.503). Morphology of first-passage (P1) chondrocytes in a monolayer culture isolated from normal biopsies (a) and from the edge of the debrided lesion (b). 
THE JOURNAL OF BONE AND JOINT SURGERY The monolayer expansions led to de-differentiation of the chondrocytes. The decrease in COL2 was 72-fold and 230-fold for control and lesion edge biopsies, respectively. Similar downregulation of AGR was seen in both cell subtypes, but COL1 and VER were upregulated only in cells from the edge. After seeding into alginate hydrogel, both cell subtypes showed similar re-differentiation potential. COL2 increased 26-fold in both control and edge cells, whereas expression of AGR increased about threefold. COL1 and VER decreased slightly in edge cells, yet in control cells their expression did not change. All the calculated differentiation indices were lower in edge biopsies. Control samples had COL2/COL1 approximately three times (p = 0.347) and AGR/VER seven times (p = 0.04) higher than the samples from the lesion edges. Additionally, the cells from the edges de-differentiated in a monolayer culture system six times (p = 0.012) and three times more (p = 0.003) for COL2/COL1 and AGR/VER, respectively. A 7.5-fold (p = 0.566) higher re-differentiation value for COL2/COL1 and a 3.5-fold higher (p = 0.449) for AGR/VER in the alginate hydrogel were observed for chondrocytes obtained by the normal harvesting procedure.
Discussion
The main purpose of this study was to determine whether cartilage samples obtained when debriding the edge of the lesion could be used as an alternative source of cells for ACI. The results clearly show that the cells from the edge of the lesion and normal cartilage do not differ in terms of viability, proliferative capacity or morphology. However, important differences were noted in the initial cell yield and in the gene expression levels of typical chondrocytic marker molecules.
Despite the lower number of cells isolated from the edges, their viability was comparable with that of cells from normal tissue. The edge of a chronic chondral lesion contains sclerotic bone, fibrous tissue and a mixture of degenerative and normal cartilage. 13 Even though special care was taken to harvest only macroscopically intact cartilage from the edge of the lesion, it is likely that this material also contained tissue lacking in chondrocytes. According to the calculated population doublings, both cell types showed a high capacity for proliferation. After the first passage, the cumulative population doubling value was about 8.6 for both cell types. 6 cells for the ACI procedure if they are implanted at densities similar to the physiological ones in the knee joint. [14] [15] [16] However, in order to provide sufficient living cells from edge biopsies, the whole lesion would need to be debrided during the initial arthroscopy. This would leave the newly formed edge of the lesion exposed to overloading and an imbalance in joint homeostasis, therefore further debridement might be required when cells are grafted. 4 The phenotypical status of the cells from edge of the lesion and those from normal cartilage was assessed using real-time PCR. Gene expression of COL1, COL2, AGR and VER were analysed, as they have been recognised as describing the phenotypical status of chondrocytes. 12, [17] [18] [19] Edge cells showed a poorer hyaline-like phenotype already [17] [18] [19] [20] [21] This process is to some extent reversed by seeding dedifferentiated cells into scaffold material that mimics the 3D environment of the native tissue. 17, [22] [23] [24] Cells from edge biopsies de-differentiated to a higher degree than those obtained from the normal harvesting procedure. After seeding de-differentiated cells into alginate hydrogel, both cell types showed a similar capacity for re-differentiation. Owing to the differences in expression profile after the beginning of cell isolation and monolayer expansion, COL2 and AGR were respectively 3.7 times and twice as high in cells from a normal harvesting in the alginate hydrogel. The same results were confirmed by calculating the differentiation indices: COL2/COL1 and AGR/VER were higher under all culture conditions in cells from the normal harvesting procedure and showed a superior hyaline phenotype. In spite of marked differences between the two types of biopsy, statistical significance could not be reached on all occasions, probably due to the well-known high inter-individual variability in gene expression. 17, 19 To our knowledge there are only two studies that have looked at chondrocyte cultivation from the edge of the lesion. Biant and Bentley 25 compared pellet cultures of chondrocytes from normal tissue, debrided tissue and stem cells from bone marrow aspirate, which were grown in a chondrogenesis-inducing medium with TGF-β1. According to their histological and immunohistochemical examination, similar differentiation of all three cell types was established. However, expanded chondrocytes in the ACI procedure are implanted into a cartilage lesion that is surrounded by mature chondrocytes, whereas TGF-β1 is found only in the proliferative and upper hypertrophic zones during endochondral ossification. Furthermore, Smad6 and Smad7, regulatory molecules that inhibit signalling by members of the TGF-β superfamily, are detected mainly in mature chondrocytes. 26, 27 Several studies have also shown that under current protocol conditions mesenchymal stem cells undergo hypertrophy. 28, 29 As the described experimental conditions did not resemble those of implanted chondrocytes in vivo, only limited conclusions may be drawn.
Chaipinyo, Oakes and Van Damme 30 found similar rates of proliferative and qualitatively similar immunolocalisation of COL1 and COL2 in two samples of cells from debrided cartilage and normal tissue harvested post mortem. Quantification of proteoglycan synthesis revealed no significant difference between debrided and normal cells, not even in 3D collagen gel or monolayer cultures. Their study was limited not only by a low number of control biopsies, but also as a result of the inter-individual statistical comparison. In order to minimise the variability among samples in our study, biopsies of debrided tissue and healthy articular cartilage were taken from the same patient, but differences in gene expression levels were still rather high.
In summary, this study shows that chondrocytes from the debrided tissue at the edge of the articular defect show a lower cell yield and an inferior cartilage phenotype. The problem with lower cell numbers per tissue may be overcome by aggressive harvesting, but there is no adequate way of compensating for the inferior cell phenotype. As the quality of the implanted cells influences the final outcome of the cultivated autologous chondrocyte procedure, 31 we cannot recommend that cells from the edge of the lesion be used as the only source of chondrocytes for this procedure.
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